$Cocrystal Pharma (COCP.US)$ The new compounds in the public...
$Cocrystal Pharma (COCP.US)$ The new compounds in the publication are exclusively licensed and being developed by Cocrystal Pharma for COVID-19. K-State Innovations Partners handles commercial technology licensing for the university. https://www.eurekalert.org/pub_releases/2020-08/ksu-nps080320.php
免責聲明：社區由Moomoo Technologies Inc.提供，僅用於教育目的。
更多信息
評論
登錄發表評論
